Romvimza 20 MG capsule UU 8S

Ended Awarded Last action

Contract number
SPE2DR26FXS8G
Awardee
Awarding agency
Obligated
$18,756

Award facts

Contract value 100% obligated
$18,756.05 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 19, 2026, for 20 mg Romvimza capsules (8 count) with a ceiling value of $18,756.05 under firm fixed pricing.

Place of performance is Conshohocken, PA. The order is scheduled for completion by April 9, 2026. No set-aside was used. The order was issued under the parent Indefinite Delivery Contract held by Cencora, Inc. (AmerisourceBergen's parent organization) with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2031.

Quick answers

Who was awarded contract SPE2DR26FXS8G?

SPE2DR26FXS8G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 19, 2026.

How much is contract SPE2DR26FXS8G worth?

The government has obligated $18,756 on SPE2DR26FXS8G.

Is contract SPE2DR26FXS8G an order under another contract?

Yes. SPE2DR26FXS8G is a delivery order under SPE2DR25D6029, an indefinite delivery contract.

Was contract SPE2DR26FXS8G competed?

The extent of competition for SPE2DR26FXS8G was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login